Morphotek is a biotechnology startup that was founded in 1999. The company specializes in the development of antibody-based therapeutics for the treatment of cancer, inflammation, and infectious diseases. Their last investment was a $2.50M grant investment on 21 October 2010 by the U.S. Department of Defense. This investment highlights the recognition and support from a prominent government institution for Morphotek's innovative approach to drug development in the biotechnology sector. With a strong focus on research and development, Morphotek has the potential to make significant advancements in the biopharmaceutical industry, making them an attractive prospect for venture capital investment.
Morphotek
Founded 1999
Grant
Total: $78.50M
Biotechnology
General Information
Company Name
Morphotek
Founded Year
1999
Industries
Biotechnology
Funding Stage
Grant
BounceWatch is an independent company data service, not affiliated with Morphotek. To contact Morphotek, visit morphotek.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
Biotechnology
About Morphotek
Funding Rounds & Investors (5)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | $2.50M | 1 |
U.S. Department of Defense
|
21 Oct 2010 |
| Series D | $40.00M | 9 |
|
12 Oct 2006 |
| Series C | $26.00M | - |
|
20 Feb 2004 |
| Series B | $10.00M | - |
|
13 Aug 2001 |
| Series A | Undisclosed | - |
|
01 May 2001 |
FAQ About Morphotek
Morphotek was founded in 1999.
Morphotek operates in Biotechnology.
Morphotek has completed 5 funding rounds, raising a total of $78.50M. The latest funding stage is Grant.
We're actively collecting intelligence on Morphotek.
Source: BounceWatch company record for Morphotek, https://bouncewatch.com/company/morphotek, updated 27 October 2024. When citing, please name BounceWatch and link this page.
